Advertisement
Screener

Clovis Oncology, Inc. Interest Paid, Including Capitalized Interest, Operating and Investing Activities

Clovis Oncology, Inc. Interest Paid, Including Capitalized Interest, Operating and Investing Activities

Clovis Oncology, Inc. reported Interest Paid, Including Capitalized Interest, Operating and Investing Activities of $3.59 million for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-04.

Discontinued › Cash Flow › Other Cash Flow Items

us-gaap:InterestPaid · last filed 2017-05-04

  • Clovis Oncology, Inc. interest paid, including capitalized interest, operating and investing activities for the quarter ending 2017-03-31 was $3.59M, a 0.00% change year-over-year.
  • Clovis Oncology, Inc. interest paid, including capitalized interest, operating and investing activities for the quarter ending 2016-12-31 was $0.00.
  • Clovis Oncology, Inc. interest paid, including capitalized interest, operating and investing activities for the quarter ending 2016-09-30 was $3.59M, a 0.03% increase year-over-year.
  • Clovis Oncology, Inc. interest paid, including capitalized interest, operating and investing activities for the quarter ending 2016-06-30 was $0.00.
  • Clovis Oncology, Inc. interest paid, including capitalized interest, operating and investing activities for fiscal 2016 was $7.19M, a 1.63% decline from fiscal 2015.
  • Clovis Oncology, Inc. interest paid, including capitalized interest, operating and investing activities for fiscal 2015 was $7.31M.
  • Clovis Oncology, Inc. interest paid, including capitalized interest, operating and investing activities for fiscal 2014 was $0.00.
Period endInterest Paid, Including Capitalized Interest, Operating and Investing Activities 3 monthInterest Paid, Including Capitalized Interest, Operating and Investing Activities 6 monthInterest Paid, Including Capitalized Interest, Operating and Investing Activities 9 monthInterest Paid, Including Capitalized Interest, Operating and Investing Activities 12 month
2017-03-31$3.59M
10-Q · filed 2017-05-04
$3.59M
derived: sum of 2 quarters · filed 2017-05-04
$7.19M
derived: sum of 3 quarters · filed 2017-05-04
$7.19M
derived: sum of 4 quarters · filed 2017-05-04
2016-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23
$3.59M
derived: sum of 2 quarters · filed 2017-02-23
$3.59M
derived: sum of 3 quarters · filed 2017-02-23
$7.19M
10-K · filed 2017-02-23
2016-09-30$3.59M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04
$3.59M
derived: sum of 2 quarters · filed 2016-11-04
$7.19M
10-Q · filed 2016-11-04
$7.19M
derived: sum of 4 quarters · filed 2017-05-04
2016-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09
$3.59M
10-Q · filed 2016-08-09
$3.59M
derived: sum of 3 quarters · filed 2017-05-04
$7.19M
derived: sum of 4 quarters · filed 2017-05-04
2016-03-31$3.59M
10-Q · filed 2017-05-04
$3.59M
derived: sum of 2 quarters · filed 2017-05-04
$7.19M
derived: sum of 3 quarters · filed 2017-05-04
$7.19M
derived: sum of 4 quarters · filed 2017-05-04
2015-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23
$3.59M
derived: sum of 2 quarters · filed 2017-02-23
$3.59M
derived: sum of 3 quarters · filed 2017-02-23
$7.31M
10-K · filed 2017-02-23
2015-09-30$3.59M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04
$3.59M
derived: sum of 2 quarters · filed 2016-11-04
$7.31M
10-Q · filed 2016-11-04
2015-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09
$3.71M
10-Q · filed 2016-08-09
2015-03-31$3.71M
10-Q · filed 2016-05-09
2014-12-31$0.00
10-K · filed 2017-02-23